f Where to Next after BASIL-2 and BEST-CLI?

References

1. FarberA. MenardM.T. ConteM.S. KaufmanJ.A. PowellR.J. ChoudhryN.K. HamzaT.H. AssmannS.F. CreagerM.A. CzirakyM.J. DakeM.D. JaffM.R. ReidD. SiamiF.S. SopkoG. WhiteC.J. van OverM. StrongM.B. VillarrealM.F. McKeanM. AzeneE. AzarbalA. BarlebenA. ChewD.K. ClavijoL.C. DouvilleY. FindeissL. GargN. GasperW. GilesK.A. GoodneyP.P. HawkinsB.M. HermanC.R. KalishJ.A. KoopmannM.C. LaskowskiI.A. Mena-HurtadoC. MotaganahalliR. RoweV.L. SchanzerA. SchneiderP.A. SiracuseJ.J. VenermoM. RosenfieldK. BEST-CLI Investigators Surgery or endovascular therapy for chronic limb-threatening ischemia.N. Engl. J. Med.2022387252305231610.1056/NEJMoa220789936342173
   [Google Scholar]
2. BradburyA.W. MoakesC.A. PopplewellM. MeechamL. BateG.R. KellyL. ChetterI. DiamantopoulosA. GaneshanA. HallJ. HobbsS. HoulindK. JarrettH. LockyerS. MalmstedtJ. PatelJ.V. PatelS. RashidS.T. SaratzisA. SlinnG. ScottD.J.A. ZayedH. DeeksJ.J. BASIL-2 Investigators A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial.Lancet2023401103901798180910.1016/S0140‑6736(23)00462‑237116524
   [Google Scholar]
3. PopplewellM.A. MeechamL. DaviesH.O.B. KellyL. EllisT. BateG.R. MoakesC.A. BradburyA.W. Editor’s choice – bypass versus angioplasty for severe ischaemia of the leg (BASIL) prospective cohort study and the generalisability of the basil-2 randomised controlled trial.Eur. J. Vasc. Endovasc. Surg.202467114615210.1016/j.ejvs.2023.09.04137778500
   [Google Scholar]
4. D’AngeloO MenardMT FarberA Common criticisms and rebuttals of the best endovascular versus best surgical therapy in patients with chronic limb-threatening ischemia (best-cli) trial.Ann Vasc Surg2024S0890-509624001490015310.1016/j.avsg.2023.12.100
   [Google Scholar]
5. ParaskevasK.I. VeithF.J. Surgery or endovascular therapy for patients with chronic limb-threatening ischemia? What do BASIL-2 and BEST-CLI tell us.Angiology2024331972412334210003319724123342110.1177/0003319724123342138336359
   [Google Scholar]
6. MenardM.T. FarberA. PowellR.J. RosenfieldK. ConteM.S. HamzaT.H. KaufmanJ.A. CzirakyM.J. CreagerM.A. DakeM.D. JaffM.R. ReidD. SopkoG. WhiteC.J. StrongM.B. van OverM. ChisciE. GoodneyP.P. GrayB. KayssiA. SiracuseJ.J. ChoudhryN.K. BEST-CLI Investigators Quality of life in patients with chronic limb-threatening ischemia treated with revascularization.Circulation2024149161241125310.1161/CIRCULATIONAHA.123.06527738597097
   [Google Scholar]
7. VenermoMA FarberA SchanzerA Reduction of major amputations after surgery versus endovascular intervention: The BEST-CLI randomised trial.Eur J Vasc Endovasc Surg.2024S1078-5884240049200501
   [Google Scholar]
8. ConteM.S. AzeneE. DorosG. GasperW.J. HamzaT. KashyapV.S. GuzmanR. Mena-HurtadoC. MenardM.T. RosenfieldK. RoweV.L. StrongM. FarberA. Secondary interventions following open vs. endovascular revascularization for chronic limb threatening ischemia in the BEST-CLI trial.J. Vasc. Surg.202479614281437.e410.1016/j.jvs.2024.02.00538368997
   [Google Scholar]
9. RiccoJB RoigerRJ SchneiderF Editor’s choice – Infra-inguinal endovascular revascularisation and bypass surgery for chronic limb threatening ischaemia: A retrospective european multicentre cohort study with propensity score matching.Eur J Vasc Endovasc Surg2023664531540
   [Google Scholar]
10. ZarrintanS RahgozarS RossEG Endovascular therapy versus bypass for chronic limb-threatening ischemia in a real-world practice.J Vasc Surg2024S0741-521424010930110010.1016/j.jvs.2024.04.067
    [Google Scholar]
11. MessihaD. PetrikhovichO. LortzJ. PinsdorfD. HogrebeK. KnuschkeR. HeringR. SchulzM. RassafT. RammosC. Underutilization of guideline-recommended therapy in patients 80 years and older with peripheral artery diseases.Vasa20235260301-1526/a00109410.1024/0301‑1526/a00109437867477
    [Google Scholar]
12. DaskalopoulouS. DaskalopoulosM. LiapisC. MikhailidisD. Peripheral arterial disease: A missed opportunity to administer statins so as to reduce cardiac morbidity and mortality.Curr. Med. Chem.200512444345210.2174/092986705336300915720252
    [Google Scholar]
13. MenardM.T. JaffM.R. FarberA. RosenfieldK. ConteM.S. WhiteC.J. BeckmanJ.A. ChoudhryN.K. ClavijoL.C. HuberT.S. TuttleK.R. HamzaT.H. SchanzerA. LaskowskiI.A. CzirakyM.J. DroozA. van OverM. StrongM.B. WeinbergI. Baseline modern medical management in the BEST-CLI trial.J. Vasc. Surg.2023783711718.e510.1016/j.jvs.2023.05.00637201761
    [Google Scholar]